Making Science Group, S.A. (BME:MAKS)
Spain · Delayed Price · Currency is EUR 6.40
0.00 (0.00%)
Aug 27, 2026, 3:57 PM CET
Making Science Group Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 24.83 | -1.72 | -4.09 | -0.91 | -3.49 |
Depreciation & Amortization | 2.87 | 2.79 | 2.55 | 1.41 | 3.04 |
Other Amortization | 4.67 | 3.73 | 3.01 | 2.54 | 0.79 |
Asset Writedown & Restructuring Costs | 2.67 | - | - | - | 0.03 |
Loss (Gain) on Equity Investments | - | - | 0 | -0 | - |
Stock-Based Compensation | 0.47 | 0.58 | 0.48 | 0.39 | - |
Provision & Write-off of Bad Debts | -0.36 | -0.36 | 1.36 | 0.06 | - |
Other Operating Activities | -17.32 | 1.64 | -0.84 | 2.74 | 1.08 |
Change in Accounts Receivable | -0.58 | -19.45 | -2.54 | -15.61 | -13.1 |
Change in Inventory | 11.8 | 0.25 | -0.14 | -1.36 | -1.9 |
Change in Accounts Payable | 0.6 | 14.02 | -0.62 | 19.55 | 13.67 |
Change in Other Net Operating Assets | 10.6 | -1.19 | 0.39 | 3.09 | 7.08 |
Operating Cash Flow | 38.55 | 0.33 | -0.42 | 11.9 | 7.21 |
Operating Cash Flow Growth | 11728.94% | - | - | 64.93% | 107.50% |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.17 | -0.28 | -1.07 | -1.34 | -0.67 |
Cash Acquisitions | - | - | - | 1.45 | - |
Sale (Purchase) of Intangibles | -6.8 | -5.58 | -4.84 | -3.32 | -28.73 |
Investment in Securities | -5.53 | -2.22 | -0.26 | -0.13 | - |
Investing Cash Flow | -12.5 | -8.08 | -6.17 | -3.34 | -29.4 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 11.1 | 7.05 | 0.1 | 30.21 |
Long-Term Debt Repaid | -17.63 | -19.81 | -8.44 | -5.26 | - |
Net Debt Issued (Repaid) | -17.63 | -8.71 | -1.39 | -5.16 | 30.21 |
Issuance of Common Stock | 1 | 16.73 | - | 8.9 | 10.56 |
Repurchase of Common Stock | - | - | -0.25 | -1.18 | - |
Other Financing Activities | - | - | -3.88 | -8.85 | 0.03 |
Financing Cash Flow | -16.63 | 8.03 | -5.51 | -6.3 | 40.8 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 4.68 | - | 0.29 | -1.13 | -0.3 |
Miscellaneous Cash Flow Adjustments | -4.21 | - | - | - | - |
Net Cash Flow | 9.88 | 0.27 | -11.81 | 1.13 | 18.31 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 38.38 | 0.05 | -1.49 | 10.56 | 6.54 |
Free Cash Flow Growth | 76270.18% | - | - | 61.47% | 99.94% |
Free Cash Flow Margin | 11.02% | 0.02% | -0.63% | 5.03% | 5.79% |
Free Cash Flow Per Share | 4.37 | 0.01 | -0.18 | 1.30 | 0.86 |
Levered Free Cash Flow | 8.19 | -6.27 | -4.53 | 6.35 | -23.02 |
Unlevered Free Cash Flow | 10.87 | -2.94 | -1.47 | 7.66 | -22.53 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 4.29 | 4.49 | 4.7 | 1.95 | 0.79 |
Cash Income Tax Paid | 0.46 | 1.12 | 1.29 | 0.4 | 0.13 |
Change in Working Capital | 22.41 | -6.36 | -2.9 | 5.66 | 5.76 |